On Monday, the FDA approved Truvada, the first medication intended to prevent HIV infections in people having sex with infected partners. In clinical trials where HIV-negative individuals had unprotected sex with multiple partners, including some with HIV, the pill reduced the risk of infection by 42 percent compared with a placebo. Another trial with heterosexual couples where one partner was infected found that Truvada, which is taken daily, reduced the risk by 75 percent. The FDA warned that the drug, which will cost patients about $450 a year, should be used in conjunction with other prevention methods.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- How our botched understanding of 'science' ruins everything
- 43 TV shows to watch in 2014
- 4 simple steaks you can cook in a pan
- 400,000 Americans marched for climate justice. Now what?
- Save the world... by changing how you pee
- 6 things the happiest families all have in common
- Why does Fareed Zakaria still have a job?
- Does solar energy have a battery problem?
- The science of sex: 4 harsh truths about dating and mating
Subscribe to the Week